Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.02781 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.25128 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.10985 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.56216 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.28342 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.62944 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.62329 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.79476 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.76199 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.96158 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.24994 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.27482 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.86165 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.9311 | 75 |